1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInvestigator Awards is sponsored by Neuroendocrine Tumor Research Foundation (NETRF). These awards provide funding for projects led by a single principal investigator (PI) or a team, with a scope comparable to an NIH R21 grant. The funding is intended for innovative and transformative research in neuroendocrine cancers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Investigator Awards - NETRF Investigator Awards provide $300,000 over two years ($150,000/year). Proposals typically include two aims (or three smaller aims) that describe work to be completed within the two-year award period. Projects are usually led by a single principal investigator (PI), with or without collaborators.
These awards are comparable in scope to an NIH R21 grant. This grant award totals $300,000 over two years. Up to 10% in indirect costs may be requested.
Indirect costs are included in the total budget. Grants will be paid in US dollars. The Neuroendocrine Tumor Research Foundation (NETRF) seeks investigators and teams with the tools to study neuroendocrine cancers in innovative and transformative ways.
Applicants must have an MD, PhD, MD/PhD, or equivalent degree and be appointed as faculty at the Assistant Professor level or above (or equivalent position). Research track faculty are eligible to apply. Applicants must have the skills, knowledge, and resources necessary to carry out the proposed research.
Eligible organizations include public or private institutions, such as universities, colleges, hospitals, and laboratories, both in and outside of the United States. Applications from the biotech, pharmaceutical, or for-profit life sciences industries are not eligible. Projects that bring together investigators from diverse scientific disciplines are highly encouraged.
For team applications, one principal investigator and one institution must be selected. International applications are welcome. Awardees, as a condition of acceptance, will be required to attend the annual NETRF Research Symposium.
Funds from the awarded grant should be allocated to attend the Annual NETRF Symposium. The NETRF request for applications uses a two-step process. First, applicants submit a competitive Letter of Intent (LOI).
Only one LOI may be submitted per applicant, per program. Applicants selected to advance will be invited to submit a full application. An LOI must be submitted, and all eligibility criteria must be met to be considered for the full application stage.
LOIs that do not meet these requirements will be administratively rejected. If invited, applicants must submit a full application that meets all program guidelines. Applications that do not meet these requirements will be administratively rejected.
LOIs and full applications will be peer reviewed by an independent panel of scientific experts. Grant recipients are required to submit progress reports every six months detailing scientific progress, research milestones achieved, and project-related expenditures. The reports disclose updates on publications, patents and clinical trial advances when applicable.
These reports are reviewed to ensure funds are spent appropriately and that sufficient progress is made throughout the grant term. Continued funding is contingent upon review and approval of progress and achievement of relevant milestones. Post-award reports at one, three and five years are required to measure longer-term outcomes of the funded research.
Learn how to apply for funding .
Researcher News and Grant Opportunities " * " indicates required fields State / Province / Region Country* Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Congo, Democratic Republic of the Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czechia Côte d'Ivoire Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Romania Russian Federation Rwanda Réunion Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Sweden Switzerland Syria Arab Republic Taiwan Tajikistan Tanzania, the United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkmenistan Turks and Caicos Islands Tuvalu Türkiye US Minor Outlying Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Åland Islands
According to the current listing, eligibility includes: Investigators and teams with an MD, PhD, MD/PhD, or equivalent degree, appointed as faculty at the Assistant Professor level or above (or equivalent position). Research track faculty are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows $300,000 over two years ($150,000/year). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Investigator Awards is funded by Neuroendocrine Tumor Research Foundation (NETRF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.